Redeye shares its initial take on BONESUPPORT's Q3 2026 report. Sales and EBIT came in ahead of both our estimates and consensus, driven by strong CERAMENT G US sales. We view the report positively, as it continues to reinforce the profitable sales growth story. We expect the share to trade upwards 7-10% today.
LÄS MER
